News

 A healthcare worker administers a dose of the Covid-19 preventive vaccine to a beneficiary in Gurugram, Wednesday, May 11, 2022. (PTI)

 A healthcare worker administers a dose of the Covid-19 preventive vaccine to a beneficiary in Gurugram, Wednesday, May 11, 2022. (PTI)

Here is a curation of top Covid-related news of the day

# Long Covid study: The Indian Council of Medical Research (ICMR) is funding a study to determine whether a drug named colchicine can be used to treat long-Covid symptoms.

https://www.thehindubusinessline.com/news/science/icmr-to-fund-clinical-trial-for-long-covid-treatment/article65403833.ece

# More on long-covid, this from China: Two years after the outbreak of Covid, about half of the patients who were hospitalised, continue to have at least one symptom, says a study touted to be the longest follow-up study till date and published in  The Lancet Respiratory Medicine.

https://www.thehindubusinessline.com/news/national/half-of-those-hospitalised-with-covid-showed-at-least-one-symptom-two-years-on/article65404440.ece

# Daily tally: India reported 2,827 new cases of Covid-19 and 24 deaths in the last 24 hours.

https://www.thehindubusinessline.com/news/covid-19-vaccination-in-india-over-1908-cr-total-doses-administered-so-far/article65406373.ece

# After Covid, geo-political challenges worry corporates: With Covid-19 becoming more “manageable” and expected to come in waves, drug-maker Cipla sees uncertainty now coming from geopolitical challenges in different parts of the world.

https://www.thehindubusinessline.com/companies/geopolitical-challenges-across-the-world-cast-a-shadow-of-uncertainty-ciplas-umang-vohra/article65404970.ece

Published on May 12, 2022

COMMENTS

  1. Comments will be moderated by The Hindu editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not ‘the’, n is not ‘and’).
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.